Therefore, our investigation suggests that low BUD31 expression is a potential prognostic factor for predicting overall survival and RFS as shown in several other types of cancers, including testicular germ cell tumor, ovarian cancer, lung squamous cell carcinoma, kidney renal papillary cell carcinoma, and thyroid carcinoma. This evidence concerns the gene BUD31 and testicular germ cell tumor.